Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceChange in ReceivablesChange in Working CapitalDeferred TaxesNet Debt Issuances and RepaymentsOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Beginning Cash Balance: 2022-2024

Historic Beginning Cash Balance for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Dec 2024 value amounting to $3.7 million.

  • Zhengye Biotechnology Holding's Beginning Cash Balance was N/A to $6.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 1218.42% up from last year.
  • As of FY2024, Zhengye Biotechnology Holding's Beginning Cash Balance stood at $3.7 million, which was up 1,218.42% from -$334,936 recorded in FY2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Beginning Cash Balance ranged from a high of $3.7 million in FY2024 and a low of -$334,936 during FY2023.
  • Its 3-year average for Beginning Cash Balance is $1.4 million, with a median of $935,925 in 2022.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first tumbled by 135.79% in 2023, then skyrocketed by 1,218.42% in 2024.
  • Zhengye Biotechnology Holding's Beginning Cash Balance (MRY) stood at $935,925 in 2022, then tumbled by 135.79% to -$334,936 in 2023, then surged by 1,218.42% to $3.7 million in 2024.
  • Its Beginning Cash Balance stands at $3.7 million for FY2024, versus -$334,936 for FY2023 and $935,925 for FY2022.